Session 12: Debate: NALIRIFOX or FOLFIRINOX for Treatment-Naive Metastatic Pancreatic Cancer - Discussion

Session Moderator(s)

• 

  Cathy Eng, MD, FACP, FASCO

  Vanderbilt-Ingram Cancer Center
  MD Anderson Cancer Center
• 

  Sonia Kupfer, MD

  University of Chicago

Panelist(s)

• 

  Jordan D. Berlin, MD

  Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center
• 

  Milind M. Javle, MD

  MD Anderson Cancer Center, The University of Texas